| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurologique
> Sclérose en plaques | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 5 000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Endocrinien
> Diabète et hypertension | Partenariat réglementaire
> Avec d'autres défenseurs des soins de santé | 10 000 | National | Sometimes | 119045009637 |
| We are one of three founding members of the South African Non-Communicable Disease Association. | Endocrinien
> Diabète et hypertension | Partenariat réglementaire
> Avec d'autres défenseurs des soins de santé | 10 000 | National | Sometimes | 119051187994 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurologique
> Sclérose en plaques | Influencer les politiques et la législation
> Influencer les politiques et la législation en matière de santé | 5 000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Cancer
> Cancer : la plupart des types | Influencer les politiques et la législation
> Influencer les politiques et la législation en matière de santé | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer : la plupart des types | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 10 000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurologique
> Sclérose en plaques | Plaidoyer pour la tarification et l'accessibilité financière
> Plaider pour une tarification équitable des médicaments | 5 000 | Regional | Regularly | 119035905477 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Rhumatismal
> Spondyloarthrite axiale | Plaidoyer pour la tarification et l'accessibilité financière
> Plaider pour une tarification équitable des médicaments | Over 100,000 | National | Regularly | 119051166861 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer : la plupart des types | Plaidoyer pour la tarification et l'accessibilité financière
> Participer aux négociations du comité d'examen des prix | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer : la plupart des types | Plaidoyer pour la tarification et l'accessibilité financière
> Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux | 10 000 | National | Regularly | 119044111428 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Rhumatismal
> Spondyloarthrite axiale | Plaidoyer pour la tarification et l'accessibilité financière
> Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux | Over 100,000 | National | Regularly | 119051166861 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Neurologique
> Sclérose en plaques | Amélioration des voies d'accès
> Faciliter l'accès équitable aux médicaments/soins de santé | 5 000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Cancer
> Cancer : la plupart des types | Amélioration des voies d'accès
> Faciliter l'accès équitable aux médicaments/soins de santé | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Cancer
> Cancer : la plupart des types | Contribution des patients fondée sur des données probantes
> Utilisez les informations sur les patients pour éclairer les décisions | 10 000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurologique
> Sclérose en plaques | Contribution des patients fondée sur des données probantes
> Fournir des preuves du monde réel (RWE) aux agences réglementaires | 5 000 | Regional | Regularly | 119035905477 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. Our input is informed by lived experience, patient-reported challenges, and international collaboration through global MS networks, ensuring that patient needs, equity, and sustainability are considered in decision-making processes. | Neurologique
> Sclérose en plaques | Contribution des patients fondée sur des données probantes
> Exploiter les témoignages de patients et les récits d'expériences vécues | 5 000 | Regional | Regularly | 119035905477 |
| Have engaged the Department of Health. | Rare
> Maladies rares : immunitaires | Gouvernance institutionnelle
> Assurer la représentation au sein des organes consultatifs gouvernementaux | 100 | International | Rarely | 119036013383 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Neurologique
> Sclérose en plaques | Gouvernance institutionnelle
> Travailler efficacement au sein de réseaux multi-parties prenantes | 5 000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Endocrinien
> Diabète et hypertension | Gouvernance institutionnelle
> Maintenir le statut formel d'entité d'intérêt public ou caritative | 10 000 | National | Sometimes | 119045009637 |
interactions
actions et plaidoyer
3 mentions
